Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Didanosine MeSH Descriptor Data 2025


MeSH Heading
Didanosine
Tree Number(s)
D03.633.100.759.590.616.130
D13.570.230.500.090
D13.570.583.616.130
D13.570.800.573.130
Unique ID
D016049
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D016049
Scope Note
A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. Didanosine is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase; ddI is then metabolized to dideoxyadenosine triphosphate, its putative active metabolite.
Entry Term(s)
2',3'-Dideoxyinosine
Dideoxyinosine
NSC-612049
Videx
ddI (Antiviral)
Pharm Action
Antimetabolites
Reverse Transcriptase Inhibitors
Anti-HIV Agents
Registry Numbers
K3GDH6OH08
0
Related Numbers
69655-05-6
CAS Type 1 Name
Inosine, 2',3'-dideoxy-
Previous Indexing
Dideoxynucleosides (1989)
Inosine/analogs & derivatives (1987-1989)
Public MeSH Note
92; was DIDEOXYINOSINE 1990-91
Online Note
use DIDANOSINE to search DIDEOXYINOSINE 1990-91
History Note
92; was DIDEOXYINOSINE 1990-91
Date Established
1990/01/01
Date of Entry
1989/07/14
Revision Date
2017/05/24
Didanosine Preferred
Videx Narrower
NSC-612049 Narrower
page delivered in 0.166s